ATOPIC DERMATITIS, UNSPECIFIED

Clinical trials for ATOPIC DERMATITIS, UNSPECIFIED explained in plain language.

Never miss a new study

Get alerted when new ATOPIC DERMATITIS, UNSPECIFIED trials appear

Sign up with your email to follow new studies for ATOPIC DERMATITIS, UNSPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for eczema patients who failed other treatments

Disease control Recruiting now

This study is observing how well the oral medication abrocitinib works for people with moderate-to-severe eczema (atopic dermatitis) in real-world clinics. It focuses on about 150 patients aged 12 and older who did not get enough relief or could not tolerate up to two previous bi…

Matched conditions: ATOPIC DERMATITIS, UNSPECIFIED

Sponsor: Pfizer • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ATOPIC DERMATITIS, UNSPECIFIED

Get alerted when new ATOPIC DERMATITIS, UNSPECIFIED trials appear

New hope for eczema patients who failed other treatments